New York, NYNCT07862049Now EnrollingIRB Ready

Inflammation Clinical Trial in New York, NY

Access cutting-edge inflammation treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Northwell Health

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access inflammation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related inflammation treatment provided free

Apply for This New York Location

Check if you qualify for this inflammation clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Inflammation Study in New York

Dietary patterns and physical inactivity common in Western societies have been associated with chronic low-grade inflammation and an increased risk of non-communicable health conditions. Fruits and vegetables contain polyphenols and other bioactive compounds that may have antioxidant and anti-inflammatory properties and may influence inflammatory biomarkers. This study will evaluate the effects of increased consumption of a fruit juice on inflammatory biomarkers and exercise capacity in adults with mildly elevated inflammation. Approximately 40 participants will be randomly assigned to consume one of two fruit juice interventions daily for approximately 2 weeks. Changes in C-reactive protein (CRP) and exercise capacity, assessed using a 6-minute walk test, will be evaluated before and after the intervention and compared between the two groups.

Sponsor: Northwell Health

Who Can Participate

Inclusion Criteria

Participants ages 18-65 years old
Physically and cognitively able to provide informed consent.
Asymptomatic.
Prior confirmed high normal or mild elevation of CRP (1.5- 9.9 mg/L)
Able to perform a 30-second sit-to-stand test, a 6-minute walk test and a test of grip strength.
Amenable to finger stick blood collection to determine CRP.
Willing to consume 2- 8 oz juice beverages per day, containing 25 grams of sugar each, for 2 weeks.

Exclusion Criteria

Diagnosis of:
Obstructive coronary artery disease (CAD).
Currently or recently having exertional chest pain or pressure with high-risk history of CAD.
History of heart failure.
Obstructive or restrictive lung disease.
Rheumatoid disorders that may increase CRP (lupus, RA or other rheumatic disorder).
Thromboembolic disease requiring anticoagulation.
Type 1 and insulin-dependent diabetes.
Irritable bowel syndrome or Crohn's disease.
Uncontrolled or untreated Type 2 Diabetes
Participant is required to be on a stable dose of their maintenance medications for at least 1 month prior to participation in the study.
Requiring oxygen supplementation during awake hours.
Pregnancy or planning pregnancy during the duration of the study.
Breastfeeding women.
Score of 4 on any question in the DePaul Symptom Questionnaire - Post Exertional Malaise (DSQ-PEM).
Participant, who in the medical opinion of the investigator team, is unsuitable to participate.
Known allergy to apples or cherries.
Current use of non-steroidal anti-inflammatory drugs (NSAIDs) listed below but not limited to:
Ibuprofen (Advil, Motrin)
Naproxen (Aleve, Naprosyn)
Ketoprofen (Orudis)
Meclofenamate (Ponstel)
The following steroids are excluded, but not limited to:
Prednisolone
Methylprednisolone
Hydrocortisone
Dexamethasme.
Triamnicolone acetonide
Participants who have Limited English Proficiency (LEP) are excluded because study team members are not fluent in languages other than English, and the protocol relies heavily on direct verbal communication with participants throughout the study period. The protocol also involves detailed instructions, questionnaires and symptom reporting that require clear comprehension to ensure valid data collection and participant safety. Without certified translations, interpreter services and validated non-English study instruments, there is a risk that participants may not fully understand study procedures, potential risks or their rights as research participants. This could compromise informed consent, increase the likelihood of protocol deviations and place participants at undue risk.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT07862049) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Inflammation Treatment Options in New York, NY

If you're searching for inflammation treatment options in New York, NY, this clinical trial (NCT07862049) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced inflammation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all inflammation clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in New York, NY

See all multiple myeloma clinical trials recruiting in New York — not just this study.

Browse Multiple Myeloma Trials in New York →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY